Analgesic profile of 3 new Ibuprofen lozenges (V0498TA01A 15mg, 25mg,

Analgesic profile of 3 new Ibuprofen lozenges (V0498TA01A 15mg, 25mg,

Hide study title

Status

Status :

Completed

Type of study

Phase II

Min. Age

18

Years old

Max. Age

-

Gender

All

Therapeutic area :

Central Nervous System

Disease :

Pain

Study medication :

V0498 Ibuprofen / Lozenge / 25 Mg

Phase : Phase II

Start Date :

15 February 2012

End date :

02 November 2012

Study ID : V00498 TA 201

EudraCT/CTIS number : 2011-005848-10

Results

Public links :

EU Clinical Trials Register